Tradestie Institutional Equity Comparison Engine

ZLAB vs LEGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LEGN Overall Edge

LEGN Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Legend Biotech Corporation American Depositary Shares (LEGN) driven by superior Valuation, Growth & Margin, Options & Structure while ZLAB counters with relative strength in Momentum & Technical. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus LEGN at 27.5x Forward P/E and 2.8% operating margin (+32.0% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against LEGN sits in UNCLASSIFIED (24th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LEGN
ZLAB N/M vs LEGN 27.5x Fwd P/E
Growth & Margin Winner LEGN
Op Margin -63.0% vs 2.8% ยท YoY -6.8% vs +32.0%
Momentum & Technical Winner ZLAB
1Y +9.2% vs -47.0% ยท 52W Pos 60% vs 1%
Options & Structure Winner LEGN
UNCLASSIFIED (58th %ile IV) vs UNCLASSIFIED (24th %ile IV)
ZLAB NASDAQ
Zai Lab Limited American Depositary Shares
Pharmaceutical Preparations
$23.74
-3.5% 1D
Market Cap $3.0B
1M Return +2.37%
1Y Return +9.25%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 53.5
LEGN NASDAQ
Legend Biotech Corporation American Depositary Shares
Pharmaceutical Preparations
$16.45
-6.03% 1D
Market Cap $3.6B
1M Return -11.01%
1Y Return -46.97%
Forward P/E 27.5x
Unified AI Score
42.8 / 100 HOLD
Tech 27.0 Fund 45.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZLAB +9.25% LEGN -46.97% Spread: +56.22 pp (ZLAB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZLAB TTM Op. Margin: -63.0% LEGN TTM Op. Margin: 2.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZLAB vs LEGN. Trailing 12-month operating profitability (ZLAB -63.0% vs LEGN 2.8%) and valuation multiples (ZLAB N/M vs LEGN 27.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZLAB (3) vs LEGN (7)
Institutional Metric ZLAB LEGN Criterion Row Winner
Market Capitalization Scale $3.0B $3.6B Larger Scale LEGN
Trailing P/E Ratio Valuation N/M 23.0x Lower Multiple LEGN
Forward P/E Ratio Valuation N/M 27.5x Lower Multiple LEGN
Revenue Growth (YoY) Growth -6.8% +32.0% Higher Growth LEGN
Operating Margin (TTM) Profitability -63.0% 2.8% Higher Margin LEGN
Net Profit Margin Profitability -44.9% -0.0% Higher Margin LEGN
Return on Equity (ROE) Capital Efficiency -30.0% -0.0% Higher ROE LEGN
52-Week Range Position Momentum 60% ($16โ€“$29) 1% ($16โ€“$38) Stronger Trend ZLAB
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 78% Vol 1.00ฮฒ ยท 82% Vol Lower Realized Risk ZLAB
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 42.8 / 100 (HOLD) Higher Composite ZLAB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZLAB vs LEGN Buy Guide
ZLAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 58th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ZLAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LEGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 24th %ile
IV Regime Compressed (<25th %ile)
Live LEGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZLAB nor LEGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.